Evidence map›Paper›PMID 38858157›Full record

ArticleBMJ open2024

ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) randomised controlled trial protocol.

Michael E Rezaee, Katherine M Mahon, Bruce J Trock, The-Hung Edward Nguyen, Armine K Smith, Noah M Hahn, Sunil H Patel, Max Kates

Registry-linked trialAbstract readClinical Trial Protocol
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05905276 (ERAS for Ambulatory TURBT), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05905276 nacompletednot on this map

ERAS for Ambulatory TURBT: Enhancing Bladder Cancer Care (EMBRACE) Randomized Controlled Trial Protocol

TypeinterventionalSponsorJohns Hopkins UniversityRan2023 to 2024Enrolled100ConditionsBladder CancerArmsERAS Protocol, Standard of Care
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael E RezaeeThe Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA.ORCID 0000-0002-6236-8682
Katherine M MahonThe Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Bruce J TrockThe Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA.
The-Hung Edward NguyenDepartment of Anesthesia and Critical Care Medicine, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Armine K SmithThe Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Noah M HahnThe Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Sunil H PatelThe Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA.
Max KatesThe Brady Urological Institute, Johns Hopkins Medicine, Baltimore, Maryland, USA mkates@jhmi.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTransurethral resection of bladder tumour (TURBT) is one of the more common procedures performed by urologists. It is often described as an 'incision-free' and 'well-tolerated' operation. However, many patients experience distress and discomfort with the procedure. Substantial opportunity exists to improve the TURBT experience. An enhanced recovery after surgery (ERAS) protocol designed by patients with bladder cancer and their providers has been developed. METHODS AND ANALYSIS: This is a single-centre, randomised controlled trial to investigate the effectiveness of an ERAS protocol compared with usual care in patients with bladder cancer undergoing ambulatory TURBT. The ERAS protocol is composed of preoperative, intraoperative and postoperative components designed to optimise each phase of perioperative care. 100 patients with suspected or known bladder cancer aged ≥18 years undergoing initial or repeat ambulatory TURBT will be enrolled. The change in Quality of Recovery 15 score, a measure of the quality of recovery, between the day of surgery and postoperative day 1 will be compared between the ERAS and control groups. ETHICS AND DISSEMINATION: The trial has been approved by the Johns Hopkins Institutional Review Board #00392063. Participants will provide informed consent to participate before taking part in the study. Results will be reported in a separate publication. TRIAL REGISTRATION NUMBER: NCT05905276.

Indexed as

Urinary Bladder NeoplasmsAmbulatory Surgical ProceduresCystectomyEnhanced Recovery After SurgeryFemaleHumansMalePerioperative CareRandomized Controlled Trials as TopicAdult oncologyBladder disordersPatient Reported Outcome MeasuresUrological tumoursUROLOGY

Identifiers

PMID38858157
PMCPMC11168167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.